Skip to content

Altimmune ALT Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-230,461%+285,399pp-515,860%-493,341pp-22,518.5%-151,548pp129,029.4%+131,227pp
Net margin-214,861%+260,434pp-475,295%-454,533pp-20,762.2%-145,340pp124,577.9%+126,780pp
Returns
Return on equity-50.6%+9.3pp-59.9%-13.2pp-46.6%-2.6pp-44.1%+1.6pp
Return on invested capital-62%+77.6pp-139.6%-2.0pp-137.6%+53.9pp-191.5%-36.8pp
Efficiency
Asset turnover0.0×0.0×0.0×-0×0.0×
Liquidity
Current ratio18.5×+5.4×13.1×-4.2×17.3×+6.0×11.3×+0.1×
Leverage
Debt-to-equity0.2×+0.1×0.0×0.0×0.0×
Per Share
Book value per share$2.55+46.7%$1.74-52.3%$3.65-7.7%$3.95-18.1%
Valuation
Market capitalization$558.14M-2.1%$512.81M-15.2%$604.45M-25.3%$808.67M+122%
Price / sales13,613.2×25,640.4×+24,222×1,418.9×
Price / book-2.0×4.2×+1.0×3.1×-1.3×4.4×+2.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Altimmune's ratios come from?
Every ratio is computed from Altimmune's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.